Cytek Biosciences Inc (CTKB)

Working capital turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Revenue (ttm) US$ in thousands 193,014 183,117 175,594 166,060 164,036 155,086 148,985 139,234
Total current assets US$ in thousands 392,060 422,315 424,821 425,622 454,020 443,859 443,270 439,112 431,733 439,826 216,938
Total current liabilities US$ in thousands 56,226 58,693 53,591 56,517 49,040 41,494 42,350 42,803 33,181 30,014 28,165
Working capital turnover 0.57 0.50 0.47 0.45 0.41 0.39 0.37 0.35

December 31, 2023 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $193,014K ÷ ($392,060K – $56,226K)
= 0.57

Working capital turnover measures how efficiently a company is utilizing its working capital to generate sales revenue. A higher turnover ratio indicates that the company is effectively using its working capital to support sales.

Looking at the data provided for Cytek Biosciences Inc, we can see a gradual improvement in the working capital turnover ratio over the last few quarters. The ratio has increased from 0.35 in Q1 2021 to 0.57 in Q4 2023. This suggests that the company has been able to generate more sales revenue relative to its working capital in recent quarters.

The upward trend in the working capital turnover ratio may indicate that Cytek Biosciences Inc is managing its working capital more efficiently, possibly through effective inventory management, accounts receivable collection, and accounts payable management. This improved efficiency can result in a better cash flow position and stronger liquidity for the company.

Overall, the increasing trend in Cytek Biosciences Inc's working capital turnover ratio indicates positive developments in the company's working capital management and operational efficiency. It suggests that the company is using its resources more effectively to generate sales revenue, which can be a favorable sign for investors and stakeholders.


Peer comparison

Dec 31, 2023